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Kudzu (Pueraria lobata) is one of the earliest medicinal plants used to treat alcohol abuse in traditional Chinese medicine for more
thanamillennium.However,littleisknownaboutitseﬀectsonchronicalcoholicliverinjury.Therefore,thepresentstudyobserved
theeﬀectsofpuerariaeradixextract(RPE)onchronicalcoholicliverinjuryaswellasKupﬀercells(KCs)activationtoreleasetumor
necrosis factor alpha (TNF-α) induced by gut-derived endotoxin in rats and macrophage cell line. RPE was observed to alleviate
the pathological changes and lipids deposition in liver tissues as well as the serum alanine aminotransferase (ALT), aspartate
aminotransferase (AST), and hepatic gamma-glutamyl transpeptidase (GGT) activity. Meanwhile, RPE inhibited KCs activation
and subsequent hepatic TNF-α expression and downregulated the protein expression of endotoxin receptors, lipopolysaccharide
binding protein (LBP), CD14, Toll-like receptor (TLR) 2, and TLR4 in chronic alcohol intake rats. Furthermore, an in vitro study
showed that RPE inhibited the expression of TNF-α and endotoxin receptors, CD14 and TLR4, induced by LPS in RAW264.7 cells.
In summary, this study demonstrated that RPE mitigated liver damage and lipid deposition induced by chronic alcohol intake in
r a t s ,a sw e l la sT N F - α release, protein expression of endotoxin receptors in vivo or in vitro.
1.Introduction
Alcohol abuse is a public issue and one of the major causes
of liver disease worldwide. It covered large proportion of
the deaths from liver disease not only in western world [1],
but also in the eastern countries. Since 1980s the morbidity
and mortality of alcoholic liver disease (ALD) has increased
abruptly and presented a more serious trend in recent years
in China [2].
ALD encompasses a spectrum of injury, ranging from
simple steatosis, hepatitis, and cirrhosis. In alcoholic fatty
liver, even the fatty drops disappear on abstinence and
steatosis still increase the susceptibility of hepatocyte to
further injury [3–7]. The continued ingestion of alcohol
results in the subsequent steatohepatitis characterized with
neutrophil inﬁltration, hepatocyte degeneration, ballooning,
and oncotic necrosis [8, 9] that rarely recover to normal
hepatic histology even with ethanol withdrawal [9]. Alco-
holic steatohepatitis triggers the pathological progress to
ﬁbrosis and then cirrhosis, so as to this stage appears to
represent a rate-limiting step in the progression of ALD
[10, 11]. Therefore, blocking or reversing the early-phase
histopathologic changes (steatosis and steatohepatitis) is the
key strategy of ALD treatment.
Besides alcohol metabolism and oxidant stress, endo-
toxin, a toxic lipopolysaccharide (LPS) component of the2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Mechanism of Kupﬀer cells activation releasing TNF-α to promote liver injury induced by gut-derived endotoxin in alcoholic liver
disease.
gut Gram-negative bacteria, has also been revealed to be
one of the classical mechanisms of alcoholic liver injury
[12, 13]. As a result of increased intestinal permeability
caused by alcohol, endotoxin releases into the circulation,
transporting in complex of LPS and LPS-binding protein
(LBP) and then binds to the CD14 receptor on hepatic
Kupﬀer cells (KCs). The CD14-LBP-LPS complex interacts
with toll-like receptor 4 (TLR4) to trigger a signaling cascade
in KCs that activates nuclear factor κB( N F κB) and promotes
the transcription of preinﬂammatory cytokines, especially
tumor necrosis factor alpha (TNF-α)[ 14]. TNF-α can itself
further increase gut permeability as well as oxidant stress
and induces apoptosis and production of other cytokines,
perpetuating, and progressing liver injury [15] (Figure 1).
Kudzu (Pueraria lobata) is one of the earliest medicinal
plants used to treat alcohol abuse in traditional Chinese
medicine for more than a millennium. It has been revealed
that antidipsotropic isoﬂavones isolated from radix puer-
ariae, including puerarin, daidzin, and daidzein, suppressed
the ethanol intake of rodents, abolished the development
of alcohol withdrawal symptoms [16–23], increased the
antioxidant enzymes (such as Cu/Zn SOD and catalase
[CAT]), and mitigated the hepatic oxidant injury in ethanol-
treated rats [24]. But few investigations on the mechanisms
of the radix puerariae extract (RPE) antialcoholic liver injury
were conducted comprehensively.
In the present study, we investigated the eﬀects of RPE on
chronic alcoholic liver injury in rats as well as the expression
of endotoxin receptors and TNF-α induced by gut-derived
endotoxin in vivo and in vitro.
2.MaterialsandMethods
2.1.PreparationofPRE. Radixpuerariae,therootofPueraria
lobata (Willd) Ohwi (Shanghai Leiyunshang Pharmaceutical
Co. Ltd, Shanghai, China) was powered and extracted with
70% alcohol for two hours, three times, concentrated with
the vacuum rotary evaporator and freeze-dried. The dried
powder was then dissolve in distilled water, ﬁltered, and
subjected to a macroporous resin D101 column (11.5cm ×
85.5cm), eluting with distilled water and 70% ethanol. The
70% ethanol eluting ﬂuid was dried with a rotary evaporator
and then stored desiccated in dark at 4◦C. 3.89g of RPE was
obtained from 100g of the dried Radix puerariae.
2.2. Analysis of RPE. The standard constituents used for
the quantitative analysis of RPE were puerarin, daidzin,
and daidzein, which are currently recommended for quality
control of radix puerariae. These standards were purchased
from Shanghai Win herb Medical Scientiﬁc & Technology
Development Co. Ltd (Shanghai, China).
The standard compounds and RPE were dissolved in
30% ethanol, ﬁltered through 0.2μmn y l o nﬁ l t e r s ,a n d
analyzedbyHPLCprocedures.TheHPLCapparatus(Agilent
1200 Series, USA) was employed for analysis. The chro-
matographic separation was carried out using a mixture of
acetonitrile(A)andwatercontaining0.02mol/ulphosphoric
acid (B), and the mobile phase was conducted as Table 1
demonstrating. The column eluent was monitored at UV
250nm. The chromatography was performed at room tem-
perature with a ﬂow rate of 1.0 mL/min, and 10 μLv o l u m e
was analyzed.
Analysis showed that 100mg RPE contained 49.5mg
puerarin, 1.2mg daidzin, and 0.15mg daidzein, indicating
that puerarin was the major constituent in RPE (Table 1,
Figure 2).
2.3. Animals and Treatments. Male Sprague-Dawley (SD)
rats (160 ± 10g) were obtained from Shanghai laboratory
animal center of Chinese academy of sciences (Shanghai,Evidence-Based Complementary and Alternative Medicine 3
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(21.488min), and (d) daidzein (32.314min).
Table 1: HPLC mobile phase gradient.
Time (min) Moble A (%) Mobile B (%)
0.00 15 85
25.00 35 65
30 100 0
35 100 0
China) and acclimatized for 7 days after delivery. All rats
were maintained on a reverse 12h light:12h dark cycle.
Animal handling and procedures were performed according
to international guidelines for the use and care of laboratory
animals. The experimental protocol was approved by the
local ethics committee.
Rats were divided into four groups: control (n =
10), ethanol (n = 10), ethanol plus high-dosage RPE
(240mg/kg·d, n = 10), and ethanol plus low-dosage
RPE (120mg/kg·d, n = 10) group. Lieber-DeCarli con-
trol and ethanol liquid diet were prepared according to
the prescription of Lieber-DeCarli diet [25] as described in
the previous research [26]. Rats in control group ingested
Lieber-DeCarli control liquid diet and rats in ethanol or
drug-administrated group ingested Lieber-DeCarli alcohol
liquid diet. Ethanol provided 36% energy in the alcohol
liquid diet, which was substituted by dextrin-maltose in
the control liquid diet. One liter liquid diet contains
1000Kcal energy. Reagents in the Liber-DeCarli formula
were purchased from Sinopharm Chemical Reagent Co.,
Ltd (Shanghai, China). Rats were single-cage rearing and
liquid diet was intake freely without additional water or
chow for eight weeks. At the beginning of the third week,
rats in ethanol plus high- and low-dosage RPE groups
were administrated with RPE by gavage in 240mg/kg·d
and 120mg/kg·d, respectively, the others with equal volume
of sterile water. At the end of the eighth week, rats
were anaesthetized with nembutal (45mg/kg, i.p.); liver
tissue and serum were collected and stored in −80◦C
for histological, biochemical, and Western blot analysis.
Two milliliter blood from portal vein was collected in
pyrogen-free and heparin-pretreated tube for endotoxin
detection.4 Evidence-Based Complementary and Alternative Medicine
2.4. Cell Culture and Treatment. The murine macrophage
cell line, RAW264.7 cells, (Shanghai Institutes for Biological
Sciences, Chinese Academy of Sciences, Shanghai, China)
were cultured in RPMI-1640 (GIBCO Invitrogen Corpora-
tion, CA, USA) containing 10% fetal bovine serum (FBS)
(GIBCO) in 5% CO2 incubator (Heraeus Holding GmbH,
Germany)at37◦C.Culturedfor24–48h,approximately70%
conﬂuence, RAW264.7 cells were divided into ﬁve groups:
control, LPS, 0.84mg/L RPE (containing 1nM puerarin)
plus LPS, and 8.4mg/L (containing 10nM puerarin) RPE
plus LPS group. RPE was dissolved in dimethyl sulfoxide
(DMSO) and diluted with RPMI-1640 (ﬁnal concentration
ofDMSOwas0.005‰).AfterpreincubatedwithRPEfor4h,
the cells were treated with LPS (Escherichia coli 0111:B4,
Sigma-Aldrich Co., USA) 0.1μg/mL for 2h without rinse.
Andthenthesupernatantandcellularproteinswerecollected
for assay.
2.5. LDH Secretion Test in RAW264.7. RAW264.7 cells were
cultured with 10% FBS RPMI-1640 (control), 84mg/L RPE
(containing 100nM puerarin) plus 10% FBS RPMI-1640,
840mg/L RPE (containing 1μM puerarin) plus 10% FBS
RPMI-1640, and 8.4g/L RPE (containing 10μM puerarin)
plus 10% FBS RPMI-1640, respectively. After 6 hours, the
activity of lactate dehydrogenase (LDH) in the supernatant
was detected. The LDH activity was corrected with the
cellular protein concentration in every dish and expressed as
U/pg proteins.
2.6. Histological Examination. Liver tissue was formalin-
ﬁxed and embedded in paraﬃn. Sections (4μm thick) were
stained with hematoxylin-eosin (H.E.) (Nanjing Jiancheng
Bioengineering institute, Nanjing, China) and examined
under light microscope (Olympus Medical Systems Corp.,
Tokyo, Japan).
Frozen hepatic tissue (7μm thick) embedded in opti-
mum cutting temperature (OCT) compound (Sakura
Finetek USA, Inc., CA, USA) was stained with oil red O
(Sinopharm Chemical Reagent Co., Ltd, Shanghai, China)
for hepatic lipid observation (Olympus Medical Systems
Corp., Tokyo, Japan).
2.7. Serum ALT and AST Assay. Activity of alanine amino-
transferase (ALT), aspartate aminotransferase (AST) in
serum was determined with the corresponding biochemical
assay kits (Nanjing Jiancheng Bioengineering institute, Nan-
jing, China).
2.8. Hepatic GGT Assay. Liver tissue (100mg) was homoge-
nized in 1mL 0.9% NaCl. The homogenate was centrifuged
at 1,000g, 4◦C for 15min, the supernatant was removed into
clean tubes and centrifuging at 3,000g for 10min, avoiding
the upper adipose and removing the transparent for gamma-
glutamyl transpeptidase (GGT) assay (Nanjing Jiancheng
Bioengineering institute, Nanjing, China).
2.9. Hepatic TG Assay. Liver tissue (200mg) was homog-
enized in 3mL ethanol-acetone mixture (1:1 in volume).
The total hepatic triglyceride (TG) extracted in the medium
at 4◦C overnight and then, centrifuged at 1,000g, 4◦Cf o r
20min, the supernatant was removed for TG assay with
TG analysis kits (Dongou Bioengineering Co. Ltd, Zhejiang,
China).
2.10. Endotoxin Assay in Plasma from Portal Vein. Blood col-
lected from portal vein was centrifuged at 500g, 4◦C
for 15min, plasma was removed immediately for analysis,
according to the instruction of Pyrochrome limulus ame-
bocyte lysate (LAL) kit (Cat NO. C1500, Associates of Cape
Cod, Inc., TX, USA).
2.11. Immunohistochemical Assessment of Hepatic CD68.
As discribed in previous study [27], 4μm thick paraﬃn
sections were used for immunohistochemical assessment.
Brieﬂy, after endogenous peroxidase blockage and bovine
serum albumin blockage, the samples were incubated at 4◦C
overnight, with a 1:100 dilution of anti-CD68 primary anti-
body (monoclonal anti-rat CD68, AbD Serotec, NC, USA).
Following the processing of the samples incubated with
a 1:250 dilution of horseradish-peroxidase-(HRP-) linked
goat anti-mouse IgG (sc-2031, Santa Cruz Biotechnology
Inc. Santa Cruz, CA) for 1h at 37◦C, diamino benzidine
(DAB) was applied as a chromogen and hematoxylin was
used for ﬂoor staining.
2.12. Measurement of TNF-α Level by ELISA. Liver TNF-
α was isolated as described in previous research [28], liver
pieces (1.0g) were minced thoroughly in ice-cold radioim-
munoprecipitationassaybuﬀer(150mMNaCl,5mMEDTA,
50mM Tris base, 0.3% Triton X-100, 0.03% sodium dodecyl
sulfate, 0.3% Na-deoxycholate, and 1% protease inhibitor
cocktail, pH 7.4) and lysised on ice for 30min. The
liver tissue extracts were then centrifuged at 15,000g for
20min at 4◦C. Removing the supernatants to clean tubes
and centrifuging again at 15,000g for 20min at 4◦C, the
supernatants of this spin were then used for enzyme-linked
immunosorbent assay (ELISA). TNF-α in both hepatic tissue
and the culture supernate of RAW364.7 cell was determined
by a commercially available ELISA kit (Cat. NO. KRC3012,
Invitrogen Corporation, Camarillo, CA, USA) according to
the manufacturer’s instruction. The result was corrected
by protein concentration (bicinchoninic acid [BCA] pro-
tein concentration assay kit, Beyotime Inst. Biotechnology,
Jiangsu, China).
2.13. Determinationof CD68 and Endotoxin Receptors in Liver
TissuebyWesternBlot. Asdescribedpreviously[27,29],total
proteinsinlivertissueandcelllayerswereextracted,analyzed
with BCA protein concentration assay kit (Beyotime Inst.
Biotechnology, Jiangsu, China).
Sample protein was separated by electrophoresis in
10% SDS-PAGE separating gel with Bio-Rad electrophore-
sis system (BioRad Laboratories, Hercules, CA, USA).
The primary antibodies (mouse anti-rat glyceraldehydes-3-
phosphate dehydrogenase, GAPDH antibody, 1:5000 dilu-
tion, KANGCHEN Bio-Tech Inc., Shanghai, China; mouseEvidence-Based Complementary and Alternative Medicine 5
Table 2: Liquid diets intake, body weight, and liver/body weight ratio.
Group (n) Volume of liquid diet intake (mL) Body weight (g) Liver/body weight ratio
(g/kg body weight)
Control (10) 2726 ±75 262 ±28 20.06 ±2.99
Ethanol (10) 2707 ±218 257 ±50 28.07 ±5.70
∗∗
240mg/kg·d RPE (10) 2723 ±166 269 ±22 31.17 ±4.09
120mg/kg·d RPE (10) 2726 ±141 276 ±24 29.45 ±4.61
∗∗P<0.01, versus control.
anti-rat CD68 antibody, 1:100 dilution, AbD Serotec, NC,
USA; mouse anti-rat CD14 antibody, 1:200 dilution, Santa
Cruz biotechnology Inc., CA, USA; goat anti-rat LBP
antibody, 1:100 dilution, Santa Cruz biotechnology Inc.,
CA, USA; rabbit anti-rat TLR2 antibody, 1:2000 dilution,
Epitomics, Inc. CA, USA; rabbit anti-rat TLR4 antibody,
1:200 dilution, Santa Cruz biotechnology Inc., CA, USA)
were incubated at 4◦C overnight. The corresponding HRP-
conjugated secondary antibodies (goat anti-mouse IgG,
goat anti rabbit-IgG peroxidase linked antibody, 1:5000
dilution, Santa Cruz Biotechnology Inc., CA, USA; rabbit
anti-goat-IgG, peroxidase linked antibody, 1:5000 dilution,
Jackson ImmunoResearch Laboratories Inc., PA, USA) were
incubated at room temperature for 1h. The ECL kit (Pierce
Biotechnology Inc., Rockford, USA) and the Furi FR-980
image analysis system (Shanghai Furi Co., Shanghai, China)
were employed for revealing and quantitative analysis of the
blots. GAPDH protein was used as the internal control.
2.14. Statistical Analysis. All results were expressed as mean
± SD. The data were analyzed using a one-way analysis
of variance (ANOVA) followed by the least signiﬁcant
diﬀerence (LSD) post hoc test. T-test is employed for the
comparison of two parameters. Diﬀerences were considered
statistically signiﬁcant if the P value < 0.05.
3. Results
3.1. Liquid Diets Intake, Body Weight, and Liver/Body Weight
Ratio. At the end of the eighth week, the total volume of
liquid diets and the average body weight was no signiﬁcantly
diﬀerent in various groups (P>0.05). The liver/body
weight ratio of rats fed with ethanol liquid diets increased
signiﬁcantly compared with that of rats in control group
(P<0.01), and there is no signiﬁcance statistically between
RPE groups and ethanol group (Table 2).
3.2. Eﬀects of RPE on Live Injury Induced by Chronic Alcohol
Intake. Chronic alcoholic liver injury was examined by
biomarkers of liver damage and histological changes in
liver tissue. The serum ALT and AST activities signiﬁcantly
increasedinethanolgroupcomparedwiththatinthecontrol
(ALT: 124.02 ± 41.68U/L versus 21.81 ± 7.90U/L, P<
0.01; AST: 81.25 ± 30.16U/L versus 26.70 ± 7.99U/L,
P<0.01). The serum ALT of rats in administration with
high-dosage RPE group was obviously decreased (87.26 ±
31.37U/L versus 124.02 ± 41.68U/L, P<0.05). The activity
of serum AST in high-dosage RPE group demonstrated
similar trends (53.51 ± 19.16U/L versus 81.25 ± 30.16U/L,
P<0.05). Decrease of these two biomarkers in low-dosage
RPE group did not appear statistically signiﬁcance (ALT:
92.58 ± 32.14U/L versus 124.02 ± 41.68U/L, P>0.05;
AST: 69.33 ± 23.72U/L versus 81.25 ± 30.16U/L, P>0.05).
On the other hand, hepatic GGT activity increased after
ethanol liquid diet intake obviously (49.75 ± 3.97U/μgpro.
versus 10.83 ± 2.11U/μgpro., P<0.01), and after RPE
administration, hepatic GGT activity decreased signiﬁcantly
(14.71 ± 2.90U/μgpro. versus 49.75 ± 3.97U/μgpro.,P<
0.01; 15.63 ± 2.19U/μgpro. versus 49.75 ± 3.97U/μgpro.,
P<0.01) (Figure 3(c)).
After chronic alcohol intake for eight weeks, the
macrovesicular steatosis was observed in the most region
of lobule, predominantly in centrilobular regions. Lipid
vacuoles occupied much of the hepatocyte cytoplasm, and
the nucleus and other organelles were pushed to the
periphery of the cell. Some hepatocytes appeared bloated,
with a wispy, rareﬁed cytoplasm. The inﬂammatory cells,
such as neutrophil and lymphocytes, scattered located in
the pericellular region. RPE of high-dosage or low-dosage
treatment alleviated the pathological changes mentioned
above (Figure 3(a)).
3.3. Eﬀects of RPE on Hepatic Lipid Deposition. The concen-
tration of TG in liver tissue and oil red O staining of liver
tissuesectionwereemployedtodemonstratethehepaticlipid
deposition.
The total TG extracted by liver tissue homogenization
was tested. As expected, chronic alcohol exposure elicited
almost 5-fold increase in hepatic TG levels as compared
with control animals (103.53 ± 13.59mg/g liver tissue versus
22.39 ± 9.19mg/g liver tissue, P<0.01). The levels of
hepatic TG decreased remarkably in RPE-treated animals
(high-dosage RPE, 72.90 ± 24.15mg/g liver tissue versus
103.53 ± 13.59mg/g liver tissue, P<0.01; low-dosage RPE,
95.64 ± 9.41mg/g liver tissue versus 103.53 ± 13.59mg/g
liver tissue, P<0.05) (Figure 3(c)).
Oil red O staining slides showed that in the hepatocytes
cytoplasm of chronic drinking rats, there were large droplets
colored with oil red O, which were widespread distributed
in the hepatic lobule, indicating severe steatosis in alcohol
intake animals. In animals treated with RPE in high or
low-dosage, the droplets were smaller and limited, which
indicated that hepatic steatosis was mitigated with RPE
administration (Figure 3(b)).6 Evidence-Based Complementary and Alternative Medicine
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Figure 3:EﬀectsofRPEonliverinjuryandlipiddepositioninducedbyLieber-DeCarlidiet.(a)HistologicalobservationontheH.E.sections
(original magniﬁcation, ×200). (b) Hepatic lipid droplets observation on red O staining sections (original magniﬁcation, ×200). (c) Serum
ALT, AST, hepatic GGT, and TG variation. Values represent the mean ± SD of 10 rats. ∗P<0.05, versus control; #P<0.05, versus ethanol;
∗∗P<0.01, versus control, ##P<0.01, versus ethanol.
3.4. Endotoxin Level in the Portal Vein and Hepatic TNF-
α Concentration. Endotoxin level in the portal vein reﬂects
the situation of endotoxin leakage from gut and indicates
the permeability of intestinal wall, indirectly. In the present
study, the endotoxin level in the portal vein was found
increasingly remarkably after long-term ethanol intake
(0.538 ± 0.09EU/mL versus 0.367 ± 0.052EU/mL, P<
0.05); however, not varying after RPE administration (high-
dosage RPE versus ethanol, 0.547 ± 0.12EU/mL versus 0.538
± 0.09EU/mL, P>0.05, low-dosage RPE versus ethanol,Evidence-Based Complementary and Alternative Medicine 7
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Figure 4:EﬀectsofRPEonendotoxinintheportalveinandhepatic
TNF-α concentration. (a) Endotoxin level in portal vein, (b) TNF-α
concentration in liver tissue. Values represent the mean ± SD of 10
rats. ∗∗P<0.01, versus control, #P<0.05, versus ethanol.
0.54 ± 0.11EU/mL versus 0.538 ± 0.09EU/mL, P>0.05)
(Figure 4(a)). This result suggested that chronic alcohol
exposure promoted endotoxin leakage from intestine, which
was not inhibited by RPE administration.
After entering circulation, the gut-derived endotoxin
activates Kupﬀer cells to release preinﬂammatory factors,
such as TNF-α, promoting liver injury. In the present
study, hepatic TNF-α was detected and it was observed
that hepatic TNF-α concentration increased signiﬁcantly in
ethanol group (88.18 ± 12.08μg/mgpro. versus 33.76 ±
6.50μg/mgpro., P<0.05), and with RPE administration,
it decreased obviously (68.64 ± 10.19μg/mgpro. versus
88.18 ± 12.08μg/mgpro., P<0.05; 66.70 ± 17.66μg/mg
pro. versus 88.18 ± 12.08μg/mgpro., P<0.05), which is
inconsistent with the RPE eﬀects on endotoxin level in portal
vein (Figure 4(b)).
3.5. Eﬀects of RPE on Kupﬀer Cells Activation and Protein
Expression of Endotoxin Receptors in Liver. Since no obvious
inhibitory eﬀect of RPE on endotoxin leakage from gut
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Figure 5: Eﬀects of RPE on Kupﬀer cells activation in liver. (a)
Hepatic CD68 expression detected with immunohistology (original
magniﬁcation, ×400), (b) Hepatic CD68 expression detected with
western-blot. Values represent the mean ± SD of three independent
experiments. ∗P<0.05, versus control; #P<0.05, versus ethanol.
was observed, the eﬀect of RPE on KCs activation and
endotoxin receptors protein expression were then detected
for investigating the mechanism of RPE block TNF-α release.
CD68/macrosialin, a transmembrane protein expressed
by activated tissue macrophages [30], was detected as a
marker of the activated KCs. Immunohistological assay
showed that few CD68-positive staining was observed in the
hepatic sinusoidal of control rats (Figure 5(a)). The positive
staining in hepatic tissue was stronger and the areas were
enlargedintheliversofethanol-dietraisedrats(Figure5(a)).
While CD68 expression decreased in the liver sections of
RPE high- or low-dosage administrated rats, respectively
(Figure 5(a)), these results were conﬁrmed by western-
blotting assay (Figure 5(b)).
LBP, the essential protein for LPS-transferring in the
circulation, is predominantly produced by liver [31], which8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Eﬀects of RPE on protein expression of endotoxin
receptors in liver. RPE inhibited protein of endotoxin receptors,
LBP, CD14, TLR4, and TLR2 (western-blot). Values represent the
mean ± SD of three independent experiments. ∗P<0.05, versus
control; ∗∗P<0.01, versus control; #P<0.05, versus ethanol.
binds to LPS of Gram-negative bacteria with high aﬃnity to
formtheLPS-LBPcomplexandtransferofLPStothesurface
receptorsontargetcells(KCs),suchasmembraneCD14.The
pattern recognition receptors, TLRs, recognize the signal of
LPSdeliveredbyLBPandCD14andactivatethedownstream
cascades. As been disclosed in protein expression assay,
in ethanol-diet group, the protein expression of endotoxin
receptorsinlivertissue,suchasLBP,CD14,TLR4,andTLR2,
were increased remarkably compared to that in control
group.WhileadministratedwithRPE,theproteinexpression
of endotoxin receptors were downregulated signiﬁcantly,
especially, in the high-dosage group (Figure 6).
The results obtained from in vivo study suggested that
RPE mitigated alcoholic liver injury and hepatic lipid
deposition induced by Lieber-DeCarli diet in rats as well as
TNF-α release, protein expression of endotoxin receptors,
and KCs activation in liver. Since the endotoxin level in
portal vein did not vary between ethanol and RPE groups,
RPE was not indicated probably to inhibit endotoxin leakage
from intestinal induced by long-term ethanol exposure. To
conﬁrm the direct eﬀects of RPE on TNF-α and endotoxin
receptors expression in KCs induced by LPS, the macrophage
cell line, RAW264.7, was employed in the subsequent
experiments in vitro.
3.6. Activity of LDH in RAW264.7 Supernatant Cultured with
Diﬀerent Concentrations of RPE. The LDH test in RAW264.7
was employed to determine the security range of RPE dosage
on cells in vitro. Increase of LDH indicates cell injury and the
toxicity of drug.
The toxicity of RPE concentration range of 84mg/L
(containing 100nM puerarin), 840mg/L (containing 1μM
puerarin), and 8.4g/L (containing 10μM puerarin) on
RAW264.7 was examined by LDH activity assay in the
culture supernatant. After cultured for 6h, as dosage of RPE
increased (84mg/L, 840mg/L, 8.4g/L), LDH activity did not
increase comparing to that in control and even decreased in
the 84mg/L RPE group. That indicated that RAW264.7 cells
cultured with 8.4g/L RPE or lower concentration was secure
(Table 3).
3.7. Eﬀect of RPE on TNF-α Secretion in RAW264.7 Cell
Culture Supernatant Induced by LPS In Vitro. The results
showed that TNF-α secretion in the supernatant increased
signiﬁcantly (LPS versus control, 1397 ± 620pg/pgpro. ver-
sus 29 ± 11pg/pgpro., P<0.01). Treatment with 0.84mg/L
(containing 1nM puerarin) and 8.4mg/L (containing 10nM
puerarin) RPE (pretreated for 4h and then coincubated with
LPS for 2h) reduced the TNF-α secretion induced by LPS
(0.84mg/LRPEversusLPS,594 ±391pg/pgpro.versus1397
± 620pg/pgpro., P<0.01; 8.4mg/L RPE versus LPS, 733 ±
288pg/pg pro. versus 1397 ± 620pg/pgpro., P<0.01). No
dosage-dependent eﬀects were observed (Figure 7).
3.8. Eﬀect of RPE on Endotoxin Receptors Protein Expression
Induced by LPS In Vitro. The protein expression of endo-
toxin receptors, CD14 and TLR4 in RAW264.7 cells, was
upregulated signiﬁcantly after stimulated by LPS. Similarly,
w i t ht r e a t m e n tb y0 . 8 4m g / La n d8 . 4m g / LR P E( p r e t r e a t e d
for 4h and then coincubated with LPS for 2h), CD14
and TLR4 protein expressions were downregulated without
dosage-dependent eﬀect (Figure 8).
4. Discussion
Kudzu (Pueraria lobata) has been used in China as an
anti-inebriation agent for centuries. Puerarin, daidzin, and
daidzein have been identiﬁed as the three major isoﬂavonoid
compounds in RPE. Previous researches mostly focused on
the antidipsotropic eﬀect of isoﬂavonoids in RPE. The most
impressive belongs to the series of studies on daidzin as
a selective inhibitor of aldehyde dehydrogenase (ALDH-2)
[32–35], and the artiﬁcial synthesis analogue with therapeu-
tic potential to reduce ethanol intake and relapse abstinent
alcoholics has been developed [36]. On the other hand,
puerarin is found to be protective against acute alcoholicEvidence-Based Complementary and Alternative Medicine 9
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Figure 7: Eﬀect of RPE on TNF-α secretion in RAW264.7 cell
culturesupernatantinducedbyLPS.RPEinhibitedTNF-αsecretion
induced by LPS in vitro. Values represent the mean ± SD of three
independent experiments. ∗∗P<0.01, versus control; #P<0.05,
versus LPS.
liver injury and alcoholism-related disorders by inhibiting
the oxidative stress [37, 38] as well as reversed liver ﬁbrosis
induced by alcohol compound with carbon tetrachloride by
promotingapoptosisofactivatedhepaticstellatecells(HSCs)
[39]. The eﬀect of RPE on chronic alcoholic liver injury and
the mechanisms were rarely reported.
In the present study, RPE was observed to inhibit chronic
alcoholic liver injury. The histological examination and the
biomarkers of liver damage, serum ALT, AST, and hepatic
GGT, revealed that RPE alleviated the liver injury induced
by Lieber-DeCarli liquid diet. The hepatic TG concentration
testsuggestedthatRPEdecreasedthehepaticlipiddeposition
induced by chronic alcohol intake, which was also observed
in the oil red staining sections.
The role of gut-derived LPS in the pathogenesis of
ALD has been widely demonstrated. LPS is the primary
endogenousendotoxinofgram-negativebacteria[12].Long-
term ethanol exposure leads to bacterial overgrowth in the
gut, disruption of intestinal barrier function, and increase
in permeability to endotoxin and bacteria. In response to
the endotoxin, KCs produce proinﬂammatory cytokines,
such as TNF-α, and cause the surrounding parenchymal
cells damage. In the present study, chronic alcohol diet
intake caused a signiﬁcant increase of endotoxin in the
portal vein and proinﬂammatory cytokine, TNF-α,s e c r e t i o n
in liver tissue. Simultaneously, the protein expression of
hepatic CD68 was upregulated remarkably, indicating KCs
activation induced by chronic alcohol diet. However, with
the administration of RPE, the level of endotoxin in the
portal vein did not vary signiﬁcantly comparing to that
in ethanol group, indicating that RPE did not inhibit the
endotoxin leakage from intestine induced by alcohol. On the
other hand, the TNF-α expression and the KCs activation
wereallinhibited,whichsupportedRPEblockingproinﬂam-
matory cytokine secretion by KCs in chronic liver injury.
TheseresultssuggestedthatRPEinhibitingproinﬂammatory
cytokine released by KCs probably did not through decrease
in endotoxin leakage from gut induced by alcohol and eﬀects
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Figure 8: Eﬀect of RPE on endotoxin receptors protein expression
induced by LPS in vitro. RPE inhibited CD14 and TLR4 protein
expression signiﬁcantly in vitro (western-blot). Values represent the
mean ± SD of three independent experiments. ∗P < 0.05, versus
control; #P < 0.05, versus LPS.
of RPE on endotoxin receptors were then evaluated in vivo
and in vitro.
The signal of endotoxin delivery depends on the endo-
toxin receptors. LBP is produced mostly by hepatocytes and
secreted into the bloodstream, where it binds with high
aﬃnitytothelipidAportionofLPSandcatalysesthetransfer
of individual LPS molecules to cell surface receptors, such
as membrane CD14 (mCD14), forming a monomeric LPS-
CD14 complex. With LBP presence, the concentration of
LPS suﬃcient for cellular activation is decreased signiﬁcantly
[40]. With the stimulation of proinﬂammatory cytokines,
LBP is constitutively synthesized in hepatocytes [41], which
is consistent with the result obtained in the present study, in
the rats by in taking alcohol diet from long-term, the protein
expression of hepatic LBP was upregulated markedly.
Molecular CD14 anchors on the membrane of peripheral
or liver resident microphage (KCs) through glycosylphos-
phatidylinositol (GPI). LPS-CD14 complex activated cells
through TLR4 [42]. It has been clearly established that
TLR4 is the speciﬁc receptor of LPS from Gram-negative
bacteria [42–44]. Signaling through TLR4 requires myeloid
diﬀerentiated protein-2 (MD-2), a secreted protein that is
closely associated with the extracellular domain of TLR4
[45]. In the present research, the protein expression of CD14
and TLR4 in liver tissue was found to be upregulated by
chronic alcohol diet intake.
The downstream of TLR4, an endotoxin signal, then
occurs through the interleukin-1(IL-1)-receptor pathway,
which is MyD88 dependent, or alternatively via a MyD88-
independent pathway [46]. Ultimately, the endotoxin signal10 Evidence-Based Complementary and Alternative Medicine
Table 3: Activity of LDH in RAW264.7 supernatant cultured with
diﬀerent concentrations of RPE.
Group LDH (U/pg proteins)
Control 14.61 ±3.06
84mg/L RPE 8.69 ±4.06
∗∗
840mg/L RPE 11.98 ±6.57
8.4g/L RPE 12.34 ±4.26
∗∗P<0.01, versus control.
activates NFκB translocation into the nucleus where it
induces proinﬂammatory gene expression, such as TNF-α,
inducing liver injury. Therefore, the endotoxin receptors are
essential for LPS signal delivery and the ultimate proinﬂam-
matory gene expression. In the present study, LBP, CD14,
and TLR4 expression in liver tissue were all downregulated
by RPE treatment comparing to that in ethanol group, which
were consistent with its eﬀect on hepatic TNF-α. Therefore,
data from study in vivo indicated RPE inhibited hepatic
TNF-α release induced by chronic alcohol intake probably
via downregulating the expression of endotoxin receptors
instead of endotoxin leakage from gut.
To observe the eﬀect of RPE on endotoxin receptors
and TNF-α expression in macrophage cells induced by LPS
directly,themacrophagecelllineRAW264.7wasemployedin
thepresentstudy.Theresultsofexperiments invitrorevealed
that RPE inhibited the TNF-α expression induced by LPS as
well as the protein expression of endotoxin receptors, CD14
and TLR4 in RAW264.7 cells, which conﬁrmed the results
obtained from study in vivo.
Inaddition,TLR2appearstoprimarilyrespondtoGram-
positive bacteria-derived lipoteichoic acid (LTA), peptido-
glycan (PGN), and mycobacterial lipoarabinomannan [46].
However, MD-2 enables TLR2 to respond to the LPS and
enhances TLR2-mediated responses to both Gram-negative
bacteria and their LPS [47]. On the other hand, the cytokines
induced by LPS, such as IL-1β or TNF-α, upregulate TLR2
mRNA expression in rat hepatocyte in vivo and in vitro [48].
In the present research, the protein expression of TLR2 was
found remarkably upregulated in the liver tissue of alcohol-
diet raised rats, but not in the LPS stimulated macrophage
cell line RAW264.7, which is consistent with our previous
studies [27]. Similarly, RPE treatment also downregulated
the TLR2 protein expression in rats with chronic alcoholic
intake.
5. Conclusion
In conclusion, the present study conﬁrmed that RPE miti-
gated liver damage and lipid deposition induced by chronic
alcohol intake as well as TNF-α release, protein expression of
endotoxin receptors in vivo and in vitro.
Conﬂict of Interests
The authors declare that there is no conﬂict of interests.
Acknowledgments
This work was supported by National Natural Science
Foundation of China (no. 81001575), Leading Academic
Discipline of Hepatology of State Administration of TCM
China (NO:2010sh), and the Innovative Research Team
in Shanghai Universities, Shanghai Municipal Education
Commission.
References
[ 1 ]R .S .O ’ S h e a ,S .D a s a r a t h y ,a n dA .J .M c C u l l o u g h ,“ A l c o h o l i c
liver disease,” Hepatology, vol. 51, no. 307, p. 328, 2010.
[2] X. Lu, M. Tao, J. Luo, Y. Geng, H. Zhao, and P. Zhao,
“Epidemiology of alcohol and liver disease,” Zhonghua Gan
Zang Bing Za Zhi, vol. 10, no. 6, pp. 467–468, 2002.
[3] I.Bykov ,H.J¨ arvel¨ ainen,andK.Lindros,“L-carnitinealleviates
alcohol-induced liver damage in rats: role of tumour necrosis
factor-alpha,” Alcohol and Alcoholism, vol. 38, no. 5, pp. 400–
406, 2003.
[ 4 ]M .F i s c h e r ,M .Y o u ,M .M a t s u m o t o ,a n dD .W .C r a b b ,“ P e r -
oxisome proliferator-activated receptor α (PPARα) agonist
treatment reverses PPARα dysfunction and abnormalities in
hepatic lipid metabolism in ethanol-fed mice,” The Journal of
Biological Chemistry, vol. 278, no. 30, pp. 27997–28004, 2003.
[5] A. Galli, J. Pinaire, M. Fischer, R. Dorris, and D. W.
Crabb, “The transcriptional and DNA binding activity of
peroxisome proliferator-activated receptor α is inhibited by
ethanol metabolism. A novel mechanism for the development
of ethanol-induced fatty liver,” The Journal of Biological
Chemistry, vol. 276, no. 1, pp. 68–75, 2001.
[6] C. P. Day and O. F. W. James, “Hepatic steatosis: innocent
bystander or guilty party?” Hepatology,v o l .2 7 ,n o .6 ,p p .
1463–1466, 1998.
[ 7 ]M .R .T e l i ,C .P .D a y ,A .D .B u r t ,M .K .B e n n e t t ,a n dO .F .W .
James, “Determinants of progression to cirrhosis or ﬁbrosis in
pure alcoholic fatty liver,” The Lancet, vol. 346, no. 8981, pp.
987–990, 1995.
[8] A.P.Bautista,“Neutrophilicinﬁltrationinalcoholichepatitis,”
Alcohol, vol. 27, no. 1, pp. 17–21, 2002.
[9] S.W.French,“Alcoholichepatitis:inﬂammatorycell-mediated
hepatocellular injury,” Alcohol, vol. 27, no. 1, pp. 43–46, 2002.
[10] A. M. Diehl, “Liver disease in alcohol abusers: clinical
perspective,” Alcohol, vol. 27, no. 1, pp. 7–11, 2002.
[11] J. T. Galambos, “Natural history of alcoholic hepatitis. 3.
Histological changes,” Gastroenterology,v o l .6 3 ,n o .6 ,p p .
1026–1035, 1972.
[12] R. K. Rao, A. Seth, and P. Sheth, “Recent advances in alcoholic
liverdiseaseI.Roleofintestinalpermeabilityandendotoxemia
in alcoholic liver disease,” American Journal of Physiology, vol.
286, no. 6, pp. G881–G884, 2004.
[ 1 3 ]D .S e t h ,P .S .H a b e r ,W .K .S y n ,A .M .D i e h l ,a n dC .P .
Day, “Pathogenesis of alcohol-induced liver disease: classical
concepts and recent advances,” Journal of Gastroenterology and
Hepatology, vol. 26, no. 7, pp. 1089–1105, 2011.
[14] G.L.Su,R.D.Klein,A.Aminlarietal.,“Kupﬀercellactivation
by lipopolysaccharide in rats: role for lipopolysaccharide
binding protein and toll-like receptor 4,” Hepatology, vol. 31,
no. 4, pp. 932–936, 2000.
[15] C. A. Bradham, J. Pl¨ u m p e ,M .P .M a n n s ,D .A .B r e n n e r ,a n dC .
Trautwein, “Mechanisms of hepatic toxicity. I. TNF-induced
liver injury,” American Journal of Physiology, vol. 275, no. 3,
part 1, pp. G387–G392, 1998.Evidence-Based Complementary and Alternative Medicine 11
[16] W. M. Keung and B. L. Vallee, “Daidzin and daidzein sup-
press free-choice ethanol intake by Syrian golden hamsters,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 90, no. 21, pp. 10008–10012, 1993.
[17] E. Benlhabib, J. I. Baker, D. E. Keyler, and A. K. Singh, “Kudzu
root extract suppresses voluntary alcohol intake and alcohol
withdrawal symptoms in P rats receiving free access to water
and alcohol,” Journal of Medicinal Food, vol. 7, no. 2, pp. 168–
179, 2004.
[18] R. C. Lin and T. K. Li, “Eﬀects of isoﬂavones on alcohol
pharmacokinetics and alcohol-drinking behavior in rats,”
American Journal of Clinical Nutrition,v o l .6 8 ,n o .6 ,p p .
1512S–1515S, 1998.
[19] E. Benlhabib, J. I. Baker, D. E. Keyler, and A. K. Singh, “Eﬀects
of puriﬁed puerarin on voluntary alcohol intake and alcohol
withdrawal symptoms in P rats receiving free access to water
and alcohol,” Journal of Medicinal Food, vol. 7, no. 2, pp. 180–
186, 2004.
[20] R.C. Lin, S. Guthrie, C.Y. Xie et al., “Isoﬂavonoid compounds
extracted from Pueraria lobata suppress alcohol preference in
a pharmacogenetic rat model of alcoholism,” Alcoholism, vol.
20, no. 4, pp. 659–663, 1996.
[21] A. K. Singh, Y. Jiang, E. Benlhabib, and S. Gupta, “Herbal
mixtures consisting of puerarin and either polyenylphos-
phatidylcholine or curcumin provide comprehensive protec-
tion against alcohol-related disorders in P rats receiving free
choice water and 15% ethanol in pure water,” Journal of
Medicinal Food, vol. 10, no. 3, pp. 526–542, 2007.
[ 2 2 ]D .H .O v e r s t r e e t ,J .E .K r a l i c ,A .L .M o r r o w ,Z .Z .M a ,Y .
W. Zhang, and D. Y. W. Lee, “NPI-031G (puerarin) reduces
anxiogenic eﬀects of alcohol withdrawal or benzodiazepine
inverse or 5-HT2C agonists,” Pharmacology Biochemistry and
Behavior, vol. 75, no. 3, pp. 619–625, 2003.
[23] G. M. Heyman, W. M. Keung, and B. L. Vallee, “Daidzin
decreases ethanol consumption in rats,” Alcoholism, vol. 20,
no. 6, pp. 1083–1087, 1996.
[24] M. K. Lee, S. Y. Cho, J. Y. Jang et al., “Eﬀects of puerariae
ﬂos and puerariae radix extracts on antioxidant enzymes
in ethanol-treated rats,” The American Journal of Chinese
Medicine, vol. 29, no. 2, pp. 343–354, 2001.
[25] C. S. Lieber and L. M. DeCarli, “The feeding of alcohol in
liquid diets: two decades of applications and 1982 update,”
Alcoholism, vol. 6, no. 4, pp. 523–531, 1982.
[26] Z. H. Fang, J. W. Cui, J. M. Cao, J. H. Peng, Q. Feng, and
Y. Y. Hu, “Preparation of Lieber-DeCarli liquid diet induced
alcoholic hepatic injury model in rats,” Z h o n gX iY iJ i eH eX u e
Bao, vol. 4, no. 6, pp. 596–600, 2006.
[27] J. H. Peng, Y. Y. Hu, Y. Cheng et al., “Eﬀect of JIANPI
HUOXUE decoction on inﬂammatory cytokine secretion
pathway in rat liver with lipopolysaccharide challenge,” World
Journal of Gastroenterology, vol. 14, no. 12, pp. 1851–1857,
2008.
[28] J. C. Lambert, Z. Zhou, L. Wang, Z. Song, C. J. McClain, and
Y. J. Kang, “Prevention of alterations in intestinal permeability
is involved in zinc inhibition of acute ethanol-induced liver
damage in mice,” Journal of Pharmacology and Experimental
Therapeutics, vol. 305, no. 3, pp. 880–886, 2003.
[ 2 9 ]J .H .P e n g ,Y .Y .H u ,Q .F e n ge ta l . ,“ E ﬀect of Jianpi Huoxue
decoction-containingserumontumornecrosisfactor-αsecre-
tion and gene expression of endotoxin receptors in RAW264.7
cells induced by lipopolysaccharide,” Chinese Journal of Inte-
grative Medicine, vol. 15, no. 3, pp. 198–203, 2009.
[30] S. S. Rabinowitz and S. Gordon, “Macrosialin, a macrophage-
restricted membrane sialoprotein diﬀerentially glycosylated in
response to inﬂammatory stimuli,” Journal of Experimental
Medicine, vol. 174, no. 4, pp. 827–836, 1991.
[31] G. L. Su, P. D. Freeswick, D. A. Geller et al., “Molecu-
lar cloning, characterization, and tissue distribution of rat
lipopolysaccharide binding protein: evidence for extrahepatic
expression,” The Journal of Immunology, vol. 153, no. 2, pp.
743–752, 1994.
[32] W. M. Keung, A. A. Klyosov, and B. L. Vallee, “Daidzin
inhibits mitochondrial aldehyde dehydrogenase and sup-
presses ethanol intake of Syrian golden hamsters,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 94, no. 5, pp. 1675–1679, 1997.
[33] W.M.KeungandB.L.Vallee,“Daidzinanditsantidipsotropic
analogs inhibit serotonin and dopamine metabolism in iso-
lated mitochondria,” Proceedings of the National Academy of
SciencesoftheUnitedStatesofAmerica,vol.95,no.5,pp.2198–
2203, 1998.
[34] N. Rooke, D. J. Li, J. Li, and W. M. Keung, “The mitochon-
drial monoamine oxidase-aldehyde dehydrogenase pathway:
a potential site of action of daidzin,” Journal of Medicinal
Chemistry, vol. 43, no. 22, pp. 4169–4179, 2000.
[35] W. M. Keung, “Biogenic aldehyde(s) derived from the action
of monoamine oxidase may mediate the antidipsotropic eﬀect
of daidzin,” Chemico-Biological Interactions, vol. 130–132, pp.
919–930, 2001.
[36] M. P. Arolfo, D. H. Overstreet, L. Yao et al., “Suppression of
heavy drinking and alcohol seeking by a selective ALDH-2
inhibitor,” Alcoholism, vol. 33, no. 11, pp. 1935–1944, 2009.
[37] M.Zhao,Y.Q.Du,L.Yuan,andN.N.Wang,“Protectiveeﬀect
of puerarin on acute alcoholic liver injury,” The American
Journal of Chinese Medicine, vol. 38, no. 2, pp. 241–249, 2010.
[38] Z. Zhang, S. Li, J. Jiang, P. Yu, J. Liang, and Y. Wang,
“Preventive eﬀects of Flos Perariae (Gehua)w a t e re x t r a c ta n d
its active ingredient puerarin in rodent alcoholism models,”
Chinese Medicine, vol. 5, article 36, 2010.
[39] S. Zhang, G. Ji, and J. Liu, “Reversal of chemical-induced liver
ﬁbrosis in Wistar rats by puerarin,” The Journal of Nutritional
Biochemistry, vol. 17, no. 7, pp. 485–491, 2006.
[40] R. R. Schumann, “Function of lipopolysaccharide (LPS)-
binding protein (LBP) and CD14, the receptor for LPS/LBP
complexes: a short review,” Research in Immunology, vol. 143,
no. 1, pp. 11–15, 1992.
[ 4 1 ] C .E l s i n g ,S .E r n s t ,N .K a y a l i ,W .S t r e m m e l ,a n dS .H a r e n b e r g ,
“Lipopolysaccharide binding protein, interleukin-6 and C-
reactive protein in acute gastrointestinal infections: value
as biomarkers to reduce unnecessary antibiotic therapy,”
Infection, vol. 39, no. 4, pp. 327–331, 2011.
[42] K. Triantaﬁlou, M. Triantaﬁlou, and R. L. Dedrick, “Interac-
tions of bacterial lipopolysaccharide and peptidoglycan with
a7 0k D aa n da n8 0k D ap r o t e i no nt h ec e l ls u r f a c eo fC D 1 4 +
and CD14−cells,” Human Immunology, vol. 62, no. 1, pp. 50–
63, 2001.
[43] G. L. Su, “Lipopolysaccharides in liver injury: molecular
mechanisms of Kupﬀer cell activation,” American Journal of
Physiology, vol. 283, no. 2, pp. G256–G265, 2002.
[ 4 4 ]T .U e s u g i ,M .F r o h ,G .E .A r t e e l ,B .U .B r a d f o r d ,a n dR .G .
Thurman, “Toll-like receptor 4 is involved in the mechanism
of early alcohol-induced liver injury in mice,” Hepatology, vol.
34, no. 1, pp. 101–108, 2001.
[45] R. Shimazu, S. Akashi, H. Ogata et al., “MD-2, a molecule that
conferslipopolysaccharideresponsivenessontoll-likereceptor
4,” Journal of Experimental Medicine, vol. 189, no. 11, pp.
1777–1782, 1999.12 Evidence-Based Complementary and Alternative Medicine
[46] S. Akira, K. Takeda, and T. Kaisho, “Toll-like receptors: critical
proteins linking innate and acquired immunity,” Nature
Immunology, vol. 2, no. 8, pp. 675–680, 2001.
[47] R. Dziarski, Q. Wang, K. Miyake, C. J. Kirschning, and D.
Gupta, “MD-2 enables toll-like receptor 2 (TLR2)-mediated
responses to lipopolysaccharide and enhances TLR2-mediated
responses to Gram-positive and Gram-negative bacteria and
their cell wall components,” The Journal of Immunology, vol.
166, no. 3, pp. 1938–1944, 2001.
[48] S. Liu, A. N. Salyapongse, D. A. Geller, Y. Vodovotz, and T.
R. Billiar, “Hepatocyte toll-like receptor 2 expression in vivo
and in vitro: role of cytokines in induction of rat TLR2 gene
expression by lipopolysaccharide,” Shock,v o l .1 4 ,n o .3 ,p p .
361–365, 2000.Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com